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ical symptoms with presence of JC virus in cerebrospinal fluid were diagnosed as Progressive Multifocal
Leukoencephalopathy (PML). The patient was negative for STAT3 mutations. To determine if other mu-
tations explain HIES and/or PML in this subject, his DNA was analyzed by whole genome sequencing.
METHODS Whole genome sequencing was completed to 30X coverage, and whole genome SNP typing
was used to complement these data. The methods revealed single nucleotide variants, structural vari-
ants, and copy number variants across the genome. Genome-wide data were analyzed for homozygous or
compound heterozygous null mutations for all protein coding genes. Mutations were confirmed by PCR
and/or Sanger sequencing. RESULTSWhole genome analysis revealed deletions near the telomere of both
copies of chromosome 9p. Several genes, including DOCK8, were impacted by the deletions but it was
unclear whether each chromosome had identical or distinct deletions. PCR across the impacted region
combined with Sanger sequencing of selected fragments confirmed a homozygous deletion from position
10,211 to 586,751. CONCLUSION While several genes are impacted by the deletion, DOCK8 deficiency
is the most probable cause of HIES in this patient. DOCK8 deficiency may have also predisposed the
patient to develop PML.
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16 Abstract
17 Purpose A 30 year-old man with a history of recurrent skin
18 infections as well as elevated serum IgE and eosinophils
19 developed neurological symptoms and had T2-hyperintense
20 lesions observed in cerebral MRI. The immune symptoms
21 were attributed to Hyper IgE syndrome (HIES) and the neu-
22 rological symptomswith presence of JC virus in cerebrospinal
23 f luid were diagnosed as Progressive Mult i focal
24 Leukoencephalopathy (PML). The patient was negative for
25 STAT3 mutations. To determine if other mutations explain
26 HIES and/or PML in this subject, his DNAwas analyzed by
27 whole genome sequencing.
28 Methods Whole genome sequencing was completed to 30X
29 coverage, and whole genome SNP typing was used to com-
30 plement these data. The methods revealed single nucleotide
31 variants, structural variants, and copy number variants across
32 the genome. Genome-wide data were analyzed for homozy-
33 gous or compound heterozygous null mutations for all protein
34 coding genes. Mutations were confirmed by PCR and/or
35 Sanger sequencing.
36Results Whole genome analysis revealed deletions near the
37telomere of both copies of chromosome 9p. Several genes,
38including DOCK8, were impacted by the deletions but it was
39unclear whether each chromosome had identical or distinct
40deletions. PCR across the impacted region combined with
41Sanger sequencing of selected fragments confirmed a homo-
42zygous deletion from position 10,211 to 586,751.
43Conclusion While several genes are impacted by the deletion,
44DOCK8 deficiency is the most probable cause of HIES in this
45patient. DOCK8 deficiency may have also predisposed the
46patient to develop PML.
47 Q1Keywords Hyper IgESyndrome .Dock8deficiency .primary
48immune deficiency . ProgressiveMultifocal
49Leukoencephalopathy (PML) . JC virus
50The hyper IgE syndromes (HIES) are rare primary immuno-
51deficiencies characterized by elevated serum IgE, dermatitis
52and recurrent skin and lung infections [1, 2]. There are two
53forms of HIES that are characterized based on their inheri-
54tance patterns: autosomal-dominant HIES (AD-HIES) and
55autosomal-recessive HIES (AR-HIES). AD-HIES is caused
56by dominant mutations in STAT3 and is characterized in
57addition to the symptoms noted above by extra-immune man-
58ifestations including skeletal, connective tissue and vascula-
59ture abnormalities [1, 2]. AR-HIES is caused by homozygous
60or compound heterozygous mutations in DOCK8, TYK2 or
61STK3, and these patients do not possess any of the extra-
62immune manifestations found in AD-HIES [3–6]. The major
63manifestations of DOCK8 deficiency leading to AR-HIES are
64recurrent viral and bacterial infections starting early in life,
65extreme eosinophilia, and elevated IgE levels. The causes of
66DOCK8 deficiency thus far described range from point
Q2 Aaron Day-Williams, Chao Sun and Ilijas Jelcic have contributed equally
to this paper.
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67 mutations and small indels to large deletions of portions of
68 DOCK8 preventing expression of the protein [3–6]. This
69 report adds to the growing body of knowledge about
70 DOCK8-deficient AR-HIES and discovers the largest pub-
71 lished deletion in the region around DOCK8. In addition, we
72 add to the literature showing the occurence of Progressive
73 Multifocal Leukoencephalopathy in DOCK8 deficient
74 individuals.
75 A 30 year old, male, Caucasian patient suffering from
76 eczematoid dermatitis developed impetiginization of the skin
77 with Klebsiella pneumonia and group A β-hemolytic strepto-
78 coccus species in July 2008. The patient was diagnosed with
79 HIES based on elevated serum IgE (26,800 kU/L) and elevat-
80 ed eosinophils (1.6×109 /L). The patient had atopic dermatitis
81 that was treated with topical corticosteroids and recurrent
82 herpesviral skin infections from the age of 6 years. There were
83 no reports of any other immunosuppressive agents. The pa-
84 tient history revealed that his parents were first cousins, how-
85 ever, no immunological diseases, opportunistic infection or
86 childhood diseases were reported in the parent’s siblings or
87 their children. In September, 2008 the patient developed a left-
88 sided sensory hemisyndrome, which progressed to a spastic-
89 atactic hemiparesis within a few weeks. A cerebral MRI
90 showed a large confluent T2-hyperintense lesion in the frontal
91 parietal central region of the right cerebral hemisphere, a small
92 T2-hyperintense lesion in the right temporal cortex, and small
93 T2-hyperintense lesions in the right cerebellar heimisphere. In
94October, 2008 the cerebrospinal fluid (CSF) of the patient was
95positive for JC polyoma virus DNA (500 copies/mL) leading
96t o t h e d i a g n o s i s o f P r o g r e s s i v e Mu l t i f o c a l
97Leukoencephalopathy (PML). Peripheral blood analysis
98showed repeatedly highly increased numbers of IgE
99(12,166–26,800 kU/l) and eosinophils (3,066–6,068/ul) and
100decreased levels of lymphocytes (296–770/ul), CD3+ T cells
101(130–265/ul), CD4+ T cells (71–169/ul), CD8+ T cells (29–
102109/ul), CD19+ B cells (173–262/ul) and NK cells (10–81/ul)
103(Table S1). After stimulation of lymphocytes with phytohe-
104magglutinin, CD3+ Tcells responded adequately as shown by
105intracellular production of interferon-γ (24 % of cells),
106interleukin-2 (25.6 %) and tumor necrosis factor-α (11.2 %).
107A screen for STAT3 mutations in April, 2009 was negative.
108The family history of first cousin parents and the absence of
109STAT3 mutations lead to the refined diagnosis of AR-HIES of
110unknown etiology. In August 2009, antiepileptic treatment
111with 3,000 mg levetiracetam and 100 mg pregabaline daily
112was started because of focal sensory epileptic seizures in the
113left hemibody. M I follow-up showed a reduced size of the
114T2-lesion within the right cerebral central region, but CSF
115JCV DNA copy number had increased tenfold (5,200 JCV
116genomic copies/mL). Until December 2010, neurological def-
117icits had progressed only mildly, but MRI showed dissemina-
118tion and enlargement of the PML lesions in the left thalamic
119region, left hemisphere, pons, and the right cerebellar
120pedunculus. The patient’s DNA was sent for whole-genome
Fig. 1 Deletion of DOCK8 in a
patient with HIES and PML. A.
Telomeric region of chromosome
9p showing the deleted region and
the impacted genes. B.
Hypothetical ploidy observed in
whole genome sequence. Note
apparent single copy coverage
near the telomere, then nearly
500 kb with no coverage, and
then diploid coverage starting at
approximately 586,000 bases.
The letters a,b,c and d show the
approximate location of PCR
primers used to confirm the nature
of the deletion. C. Results of PCR
using the primers shown in 1B.
Gel a: lanes 1,2, and 4 are
controls, lane 3 is the HIES
subject. Gels b, c and d: lane 1 is
the HIES subject, lanes 2 and 3
are control subject, lane 4 is a no
template control. Primer sets a, b,
and c produce bands from the
controls but not from the HIES
subject, and primer set d only
produces a band from the HIES
subject
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121 SNP analysis and sequencing in April, 2012. After this the
122 patient was not available for follow-up of the disease course.
123 The patient’s DNAwas whole genome sequenced (WGS)
124 by Complete Genomics Incorporated (CGI; software version
125 2.0) [7, 8] and was analyzed on the Illumina Omni 1 quad
126 genome-wide SNP array. The WGS approach used short (31–
127 35 base) sequence reads at >30X coverage mapped to the
128 reference genome using methods previously described [7] to
129 identify single nucleotide, copy number, and structural vari-
130 ants. Relative to the reference genome, the sequence of this
131 individual included 19435 missense variants, 178 nonsense
132 variants, 470 frameshift variants, and >100 copy number and
133 structural variants. Single nucleotide variants (SNVs) were
134 analyzed using the ENSEMBL Variant Effect Predictor v2.8
135 [9] on the ENSEMBL v70 database, and variant effects on the
136 annotated canonical transcripts for all genes were assessed via
137 PolyPhen2 [10] and SIFT [11]. A variant was considered
138 possibly damaging if it was determined to be either ‘probably
139damaging’ or ‘possibly damaging’ by PolyPhen2 or ‘delete-
140rious’ by SIFT. We examined known genes associated with
141immune deficiency, including the HIES genes STAT3, TYK2,
142STK3 and DOCK8, and observed no damaging mutations in
143STAT3 or STK3, heterozygosity for a possibly damaging
144missense variant in TYK2 (rs147991080, R448W, MAF
145<0.01 (http://browser.1000genomes.org/); Table S2), and
146large deletions on both copies of chromosome 9p in the
147region that includes DOCK8. The SNP array data also
148suggested a large deletion on chromosome 9p, with mostly
149non-called SNPs from approximately 194,000 to 600,000
150bases (Table S3). Given the heterozygosity and ambiguous
151function of the TYK2 variant and the obvious deletions
152around DOCK8, it is clear that the DOCK8 mutation(s) con-
153tribute to the patient’s disease.
154The WGS and SNP data were not clear on the exact
155deletion breakpoints or whether the patient was homozygous
156for the same deletion or had inherited two different deletions.
t1:1 Table 1 Genes in the deleted interval on chromosome 9, with Gene Ontology (GO;([24, 25]) biological process and function annotation, as well as
associated phenotypes in Online Medelian Inheritance in Man (OMIM; http://omim.org/)
t1:2 Gene Symbol GO biological process GO function OMIM phenotypes
(MIM number)
t1:3 DDX11L5 None None None
t1:4 WASH1 GO:0006810:transport
GO:0016197:endosomal
transport
GO:0034314:Arp2/3
complex-mediated actin nucleation
GO:0042147:retrograde
transport, endosome to Golgi
GO:0003779:actin binding
GO:0005515:protein binding
GO:0031625:ubiquitin protein
ligase binding
GO:0043014:alpha-tubulin
binding
None
t1:5 FAM138C None None None
t1:6 FOXD4 GO:0006351:transcription,
DNA-templated
GO:0006355:regulation of transcription,
DNA-templated
GO:0003677:DNA
binding
GO:0003700:sequence-specific
DNA binding transcription factor
activity
GO:0008301:DNA binding, bending
GO:0043565:sequence-specific
DNA binding
None
t1:7 CBWD1 None GO:0000166:nucleotide binding
GO:0005524:ATP binding
None
t1:8 C9orf166 None None None
t1:9 Dock8 GO:0001771;immunological synapse
formation
GO:0007264;small GTPase mediated
signal transduction
GO:0007596:blood coagulation
GO:0036336:dendritic cell
migration
GO:0043547:positive regulation of
GTPase activity
GO:0061485:memory T cell proliferation
GO:0070233:negative regulation
of T cell apoptotic process
GO:0005085:guanyl-nucleotide
exchange factor activity
GO:0005515:protein binding
Hyperimmunoglobulin E
recurrent infection syndrome,
autosomal recessive (243700)
Mental retardation, autosomal
dominant 2 (614113)
t1:10 KANK1 None None Cerebral palsy, spastic
quadriplegic, 2 (612900)
J Clin Immunol
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157 The WGS CNVanalysis estimated that the patient was homo-
158 zygous null for DOCK8 and some of KANK1, but could be
159 hemizygous towards the telomere encompassing CBWD1,
160 FOXD4, FAM138C, WASH1, and DDX11L5 (Fig. 1 panels
161 A,B), and was consistent with the hypothesis that the patient
162 had some DNA telomeric to DOCK8. The WGS analysis of
163 the p-arm from the telomere to the DOCK8 locus is compli-
164 cated by a segmental duplication that results in extremely high
165 sequence similarity to Chromosome 2 [12, 13] and ambiguous
166 sequence assembly. To resolve the breakpoints for the indi-
167 vidual’s deletion(s) we designed targeted PCR around SNPs
168 rs12353065, rs7853676 and rs11794423 which theWGS SNP
169 analysis called high confidence SNPs, theWGSCNVanalysis
170 estimated to be hemizygous, and PCR primers unique to
171 chromosome 9 could be designed (Fig. 1 panels B,C). Figure 1
172 panel C shows that the PCR with primers for the 3 SNPs (gels
173 a, b and c) are all negative illustrating that the patient is in fact
174 homozygous null from around the telomere into KANK1. To
175 resolve the exact breakpoints we designed PCR primers close
176 to the telomere and in KANK1 (PCR pair d Fig. 1 panel B,C).
177 Upon the successful amplification of this fragment we cloned
178 the DNA and Sanger sequenced the fragment.We performed a
179 global gapped alignment with the Needleman-Wunsch algo-
180 rithm of the resulting DNA fragment to chromosome 9 from
181 bases 1-700,000 (NC_000009.11) and it revealed the align-
182 ment in Supplementary Figure 1. The alignment shows a
183 massive homozygous deletion from position 10,211 to
184 586,751 that makes the patient homozygous null for the genes
185 WASH1, FAM138C, FOXD4, CWBD1, C9orf66, DOCK8
186 and most of KANK1.
187 DOCK8 deficiency is the most likely cause of HIES in this
188 subject, and may have predisposed him to the development of
189 PML. Among the genes in the deletion interval none of the
190 other genes are so obviously connected to the phenotype
191 (Table 1), and elsewhere in the genome there are no mutations
192 consistent with known inheritance patterns for HIES. Notably,
193 this is not the first case report of PML in DOCK8 deficiency
194 [14]. PML has been observed in a limited subset of PIDs that
195 includes DOCK8 deficiency, Wiskott-Aldrich Syndrome,
196 STAT1 gain of function mutations and CD40L deficiency
197 [15–20]. This observation highlights a new pathway by which
198 the ubiquitous JC virus causes PML in a small fraction of
199 individuals and further demonstrates the utility of whole ge-
200 nome sequencing for diagnosing diseases of unknown etiolo-
201 gy. DOCK8 deficiency can be treated by bone marrow trans-
202 plantation [21–23], and the possibility of PML in these indi-
203 viduals is a reason to consider early and accurate diagnosis of
204 suspect cases by genetic analysis and treatment by
205 transplantation.
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